Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAGLE-3: Gepotidacin vs Nitrofurantoin in Uncomplicated UTI
NCT04187144Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of gepotidacin in urinary tract infection (UTI), sponsored by GSK. Primary endpoint: Combined Clinical and Microbiological Response. Started Apr 2020; status: completed.
02
Drugs
gepotidacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04187144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04187144.